Federal Register / Vol. 62, No. 36 / Monday, February 24, 1997 / Notices 8255

Related to Deafness and Communication

Disorders.)

Dated: February 18, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–4481 Filed 2–21–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 United States Code,

Appendix 2), notice is hereby given of

the following meeting:

Name of Committee: National Institute on

Deafness and Other Communication

Disorders Special Emphasis Panel.

Date: March 20–21, 1997.

Time: 8:00 a.m.–5:00 p.m., March 20, 8:00

a.m.—adjourment, March 21.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda MD 20814.

Contact Person: Mary Nekola, Ph.D.,

Scientific Review Administrator, NIDCD/

DEA/SRB, EPS Room 400C, 6120 Executive

Boulevard, MSC 7180, Bethesda MD 20892–

7180, 301–496–8683.

Purpose/Agenda: To review and evaluate

Program Project applications. The meeting

will be closed in accordance with the

provisions set forth in sections 552b(c)(4) and

552b(c)(6), Title 5, United States Code. The

applications and/or proposals and the

discussion could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.173 Biological Research

Related to Deafness and Communication

Disorders)

Dated: February 18, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–4482 Filed 2–22–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Child Health and

Human Development; Notice of Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Child Health and

Human Development Initial Review

Group (IRG) meetings.

Name of IRG: Maternal and Child Health

Research Subcommittee.

Date: March 4–5, 1997.

Time: March 4—8:00 a.m.—5:00 p.m.;

March 5—8:00 a.m.—adjournment.

Place: Doubletree Hotel, 1750 Rockville

Pike, Rockville, Maryland 20852.

Contact Person: Dr. Gopal Bhatnagar, 6100

Executive Boulevard, 6100 Building—Rm.

5E03, Rockville, Maryland 20852, Telephone:

301–496–1696.

Name of IRG: Mental Retardation Research

Subcommittee.

Date: March 7, 1997.

Time: 8:00 a.m.—adjournment.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, Maryland 20814.

Contact Person: Dr. Norman Chang, 6100

Executive Boulevard, 6100 Building—Rm.

5E03, Rockville, Maryland 20892, Telephone:

301–496–1484.

Name of IRG: Medical Rehabilitation

Research Subcommittee.

Date: March 10, 1997.

Time: 8:00 a.m.—adjournment.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hills Road, Bethesda, Maryland 20814.

Contact Person: Anne Krey, 6100 Executive

Boulevard, 6100 Building—Rm. 5E03,

Rockville, Maryland 20852, Telephone: 301–

496–1696.

Name of IRG: Population Research

Subcommittee.

Date: March 27–28, 1997.

Place: Ramada Ind—Bethesda, 8400

Wisconsin Avenue, Bethesda, Maryland

20814.

Time: March 27—8:00 a.m.—5:00 p.m.;

March 28—8:00 a.m.—adjournment.

Contact Person: Dr. A.T. Gregoire, 6100

Executive Boulevard, 6100 Building—Rm.

5E01, Rockville, Maryland 20852, Telephone:

301–496–1485.

Purpose/Agenda To evaluate and review

grant applications.

The meetings will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.864, Population Research

and No. 93.865, Research for Mothers and

Children, National Institutes of Health.)

Dated: February 18, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–4484 Filed 2–21–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of General Medical

Services; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

advisory committee meeting of the

National Institute of General Medical

Sciences Special Emphasis Panel:

Committee Name: Mechanisms of

Anesthetic Action on Signal Transduction.

Date: March 26, 1997.

Time: 8:00 a.m.–until conclusion.

Place: Omni Hotel, 235 W. Main Street,

Charlottesville, Virginia 22902.

Contact Person: Irene B. Glowinski, Ph.D.,

Office of Scientific Review, 45 Center Drive,

Room 1AS–13J, Bethesda, MD 20892–6200,

301–594–2772 or 301–594–3663.

Purpose: To review and evaluate program

project applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.821, Biophysics and

Physiological Sciences; 93.859,

Pharmacological Sciences; 93.862, Genetics

Research; 93.863, Cellular and Molecular

Basis of Disease Research; 93.880, Minority

Access Research Careers [MARC]; and

93.375, Minority Biomedical Research

Support [MBRS].)

Dated: February 18, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–4485 Filed 2–21–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute on Drug Abuse

(NIDA) Initial Review Group and

Special Emphasis Panel meetings.

Purpose/Agenda: To review and evaluate

grant applications.

Name of Committee: Health Service

Research Subcommittee.

Date: March 4–5, 1997.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Raquel Crider, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: Treatment Research

Subcommittee.

Date: March 4–6, 1997.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Kesinee Nimit, M.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: NIDA Special

Emphasis Panel (Treatment).